Neuralia TMS Specialises in Pharmacogenetic Testing Across Australia
Australia, 24th Mar 2025, – Neuralia TMS, a leader in non-invasive therapeutic treatments, has announced the expansion of its services to include pharmacogenetic testing across Australia. This new offering enables the company to enhance its ability to tailor treatments to the specific needs of individual patients. The integration of pharmacogenetic testing into Neuralia TMS’s service…